Question Presented (from Petition)
1. Whether 28 U.S.C. § 46 and principles of sound judicial administration preclude a court of appeals from adding a new judge to form a new panel and redecide a case after an original three-judge panel has already decided the case and entered its judgment.
2. Whether 35 U.S.C. § 112 should be interpreted consistent with its plain text as requiring that a patent specification contain a "written description of the invention" in a form that need only be understandable to "any person skilled in the art," or whether the court of appeals properly read in a heightened requirement that allows it to deem the specification inadequate on de novo review and displaces the perspective of a person skilled in the art.
Question Presented (AI Summary)
Whether 28 U.S.C. §46 and principles of sound judicial administration preclude a court of appeals from adding a new judge to form a new panel and redecide a case after an original three-judge panel has already decided the case and entered its judgment
2023-03-22
DISTRIBUTED for Conference of 4/14/2023.
2023-03-21
Reply of petitioner Novartis Pharmaceuticals Corporation filed. (Distributed)
2023-03-03
Brief of respondent HEC Pharm Co., Ltd., HEC Pharm USA Inc. in opposition filed.
2023-02-21
Brief amici curiae of Intellectual Property Professors filed.
2023-02-21
Brief amici curiae of Retired United States Circuit Judges filed.
2023-02-21
Brief amici curiae of Law Professors and Civil Procedure Scholars filed.
2023-02-01
Motion to extend the time to file a response is granted and the time is extended to and including March 3, 2023.
2023-01-30
Motion to extend the time to file a response from February 21, 2023 to March 3, 2023, submitted to The Clerk.
2023-01-18
Petition for a writ of certiorari filed. (Response due February 21, 2023)
2022-12-08
Application (22A507) granted by The Chief Justice extending the time to file until January 18, 2023.
2022-12-06
Application (22A507) to extend the time to file a petition for a writ of certiorari from December 19, 2022 to January 18, 2023, submitted to The Chief Justice.